zkn-013
zkn-013: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOXD) | Preclinical |
Get deeper analysis on zkn-013
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis